Publication | Closed Access

Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy

HypertensionHeart FailureCardiovascular DiseaseLeft Ventricular MassValsartan Versus AmlodipinePhysiologyMedicineAntihypertensive TherapyLeft Ventricular HypertrophyPharmacotherapyCardiovascular ToxicityPharmacologyCardiologyDiastolic Function